• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

焦虑症状问卷(ASQ):编制与验证

Anxiety Symptoms Questionnaire (ASQ): development and validation.

作者信息

Baker Amanda, Simon Naomi, Keshaviah Aparna, Farabaugh Amy, Deckersbach Thilo, Worthington John J, Hoge Elizabeth, Fava Maurizio, Pollack Mark P

机构信息

Massachusetts General Hospital, Boston, Massachusetts, USA.

Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Gen Psychiatr. 2019 Dec 18;32(6):e100144. doi: 10.1136/gpsych-2019-100144. eCollection 2019.

DOI:10.1136/gpsych-2019-100144
PMID:31922090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6936972/
Abstract

BACKGROUND

The Anxiety Symptoms Questionnaire (ASQ) is a brief self-report questionnaire which measures frequency and intensity of symptoms and was developed to improve assessment of anxiety symptoms in a clinical setting. We examined the reliability and validity of the ASQ in patients with anxiety disorders and/or depression, non-clinical control subjects and college students.

METHODS

240 outpatients with generalised anxiety disorder, social anxiety disorder, panic disorder or major depressive disorder were administered the ASQ and additional questionnaires measuring depression and anxiety, as were 111 non-clinical control subjects and 487 college students. Factor analysis, Pearson's correlation coefficients and logistic regression were used to assess reliability and validity. Test-retest reliability of the ASQ was measured using a subset who were re-administered the ASQ after 4 weeks.

RESULTS

Factor analysis revealed measurement of a single dimension by the ASQ. Internal consistency and test-retest reliability were strong. The ASQ total score also significantly distinguished patients with an anxiety disorder from the clinical controls above and beyond the clinician-rated Hamilton Anxiety Scale.

CONCLUSIONS

The ASQ is a valid, reliable and effective self-rated measure of anxiety and may be a useful tool for screening and assessing anxiety symptoms in psychiatric as well as college settings.

摘要

背景

焦虑症状问卷(ASQ)是一份简短的自我报告问卷,用于测量症状的频率和强度,旨在改善临床环境中焦虑症状的评估。我们检验了ASQ在焦虑症和/或抑郁症患者、非临床对照受试者及大学生中的信度和效度。

方法

对240名患有广泛性焦虑症、社交焦虑症、惊恐障碍或重度抑郁症的门诊患者以及111名非临床对照受试者和487名大学生进行了ASQ及其他测量抑郁和焦虑的问卷测试。采用因子分析、皮尔逊相关系数和逻辑回归来评估信度和效度。使用一部分在4周后再次接受ASQ测试的受试者来测量ASQ的重测信度。

结果

因子分析显示ASQ测量的是单一维度。内部一致性和重测信度很强。ASQ总分在区分焦虑症患者与上述临床对照方面,在临床医生评定的汉密尔顿焦虑量表之外也具有显著差异。

结论

ASQ是一种有效、可靠且实用的焦虑自评工具,可能是精神科及大学环境中筛查和评估焦虑症状的有用工具。

相似文献

1
Anxiety Symptoms Questionnaire (ASQ): development and validation.焦虑症状问卷(ASQ):编制与验证
Gen Psychiatr. 2019 Dec 18;32(6):e100144. doi: 10.1136/gpsych-2019-100144. eCollection 2019.
2
[Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].[用于评估成年精神病患者社交行为频率与满意度的QFS量表的验证]
Encephale. 2006 Jan-Feb;32(1 Pt 1):45-59. doi: 10.1016/s0013-7006(06)76136-x.
3
[Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].[创伤后应激障碍的评估:一种测量工具——创伤后应激障碍检查表(PCLS)的效度验证]
Encephale. 2003 May-Jun;29(3 Pt 1):232-8.
4
A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.一种临床上有用的针对重度抑郁症DSM-5混合特征说明符的自我报告测量方法。
J Affect Disord. 2014 Oct;168:357-62. doi: 10.1016/j.jad.2014.07.021. Epub 2014 Jul 22.
5
A clinically useful anxiety outcome scale.一个具有临床应用价值的焦虑结局量表。
J Clin Psychiatry. 2010 May;71(5):534-42. doi: 10.4088/JCP.09m05264blu. Epub 2010 Mar 9.
6
A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.一种针对重度抑郁症的DSM-5焦虑痛苦特征的具有临床实用性的自我报告测量方法。
J Clin Psychiatry. 2014 Jun;75(6):601-7. doi: 10.4088/JCP.13m08961.
7
Reliability and Validity of the Korean Version of the Ask Suicide-Screening Questions (ASQ).《自杀筛查问题(ASQ)韩国版的信度和效度》。
J Korean Med Sci. 2023 Feb 13;38(6):e41. doi: 10.3346/jkms.2023.38.e41.
8
Reliability and validity of the Adolescent Stress Questionnaire in a sample of European adolescents--the HELENA study.青少年压力问卷在欧洲青少年样本中的信度和效度——HELENA 研究。
BMC Public Health. 2011 Sep 23;11:717. doi: 10.1186/1471-2458-11-717.
9
The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital.PHQ-9 在精神病院重度抑郁症患者中的信度和效度。
BMC Psychiatry. 2020 Sep 29;20(1):474. doi: 10.1186/s12888-020-02885-6.
10
[The Fear of Negative Evaluation scale (FNE): psychometric properties of the French version].[恐惧负面评价量表(FNE):法语版的心理测量特性]
Encephale. 2004 Nov-Dec;30(6):517-24. doi: 10.1016/s0013-7006(04)95465-6.

引用本文的文献

1
The TAAR1 Agonist PCC0105004 Regulates Amygdala Synaptic Plasticity to Alleviate Anxiety-Like Behaviors in Rats.TAAR1激动剂PCC0105004调节杏仁核突触可塑性以减轻大鼠的焦虑样行为。
Pharmacol Res Perspect. 2025 Apr;13(2):e70068. doi: 10.1002/prp2.70068.
2
Internal Validity and Reliability of the GAD-7 Test in Latin America.广泛性焦虑障碍7项量表(GAD-7)测试在拉丁美洲的内部效度和信度
Chronic Stress (Thousand Oaks). 2025 Mar 11;9:24705470251315260. doi: 10.1177/24705470251315260. eCollection 2025 Jan-Dec.
3
A classification system based on improved global exploration and convergence to examine student psychological fitness.

本文引用的文献

1
College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.有和没有疲劳症状的抑郁症状大学生:功能、自杀倾向、焦虑和抑郁严重程度的差异。
Ann Clin Psychiatry. 2015 May;27(2):100-8.
2
Evidence-based treatment of anxiety disorders.焦虑障碍的循证治疗。
Int J Psychiatry Clin Pract. 2006;10 Suppl 1:16-21. doi: 10.1080/13651500600552487.
3
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
基于改进的全局探索和收敛的分类系统,用于检查学生心理适应能力。
Sci Rep. 2024 Nov 9;14(1):27427. doi: 10.1038/s41598-024-78781-w.
4
Clinical Considerations for an Evidence-Based Assessment of Anxiety Disorders in Adults.成人焦虑障碍基于证据评估的临床考虑因素。
Psychiatr Clin North Am. 2024 Dec;47(4):623-639. doi: 10.1016/j.psc.2024.04.009. Epub 2024 May 23.
5
Protocol Report on the Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) Study.阿尔茨海默病经颅光生物调节治疗(TRAP-AD)研究的方案报告
Healthcare (Basel). 2023 Jul 13;11(14):2017. doi: 10.3390/healthcare11142017.
6
The cerebellum and anxiety.小脑与焦虑
Front Cell Neurosci. 2023 Feb 22;17:1130505. doi: 10.3389/fncel.2023.1130505. eCollection 2023.
7
The Feasibility of Using Smartphone Sensors to Track Insomnia, Depression, and Anxiety in Adults and Young Adults: Narrative Review.利用智能手机传感器追踪成年人和青年人的失眠、抑郁和焦虑的可行性:叙事性综述。
JMIR Mhealth Uhealth. 2023 Feb 17;11:e44123. doi: 10.2196/44123.
8
A study in University of Ruhuna for investigating prevalence, risk factors and remedies for psychiatric illnesses among students.斯里兰卡卢哈纳大学的一项研究,旨在调查学生中精神疾病的患病率、风险因素和治疗方法。
Sci Rep. 2022 Jul 27;12(1):12763. doi: 10.1038/s41598-022-16838-4.
9
Association between socioeconomic inequality and the global prevalence of anxiety and depressive disorders: an ecological study.社会经济不平等与焦虑和抑郁障碍全球患病率之间的关联:一项生态学研究。
Gen Psychiatr. 2022 May 16;35(3):e100735. doi: 10.1136/gpsych-2021-100735. eCollection 2022.
10
How Do You Treat in Your Practice?在你的临床实践中你如何治疗?
Med Acupunct. 2021 Dec 1;33(6):447-449. doi: 10.1089/acu.2021.29194.cpl. Epub 2021 Dec 16.
一项针对难治性社交焦虑障碍的增效和转换策略的双盲随机对照试验。
Am J Psychiatry. 2014 Jan;171(1):44-53. doi: 10.1176/appi.ajp.2013.12101353.
4
Toward the future of psychiatric diagnosis: the seven pillars of RDoC.走向精神疾病诊断的未来:RDoC 的七大支柱。
BMC Med. 2013 May 14;11:126. doi: 10.1186/1741-7015-11-126.
5
Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.正念冥想治疗广泛性焦虑障碍的随机对照试验:对焦虑和应激反应的影响。
J Clin Psychiatry. 2013 Aug;74(8):786-92. doi: 10.4088/JCP.12m08083.
6
Depression and suicidal ideation in college students.大学生的抑郁和自杀意念。
Psychopathology. 2012;45(4):228-34. doi: 10.1159/000331598. Epub 2012 May 22.
7
Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future.精神科诊断:DSM-IV 的过去教训和 DSM-5 的未来警示。
Annu Rev Clin Psychol. 2012;8:109-30. doi: 10.1146/annurev-clinpsy-032511-143102. Epub 2011 Oct 25.
8
Limitations of the Hamilton Anxiety Rating Scale as a primary outcome measure in randomized, controlled trials of treatments for generalized anxiety disorder.汉密尔顿焦虑评定量表作为广泛性焦虑症治疗随机对照试验主要结局指标的局限性。
Am J Psychiatry. 2010 Jan;167(1):103-4; author reply 104-5. doi: 10.1176/appi.ajp.2009.09091264.
9
A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment.基于《精神疾病诊断与统计手册》第四版焦虑症和情绪障碍共同特征的维度分类系统提案:对评估和治疗的启示
Psychol Assess. 2009 Sep;21(3):256-71. doi: 10.1037/a0016608.
10
Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial.短期心理动力心理治疗与认知行为疗法治疗广泛性焦虑症:一项随机对照试验
Am J Psychiatry. 2009 Aug;166(8):875-81. doi: 10.1176/appi.ajp.2009.09030441. Epub 2009 Jul 1.